Stocks News

LAST PRICE
58.1400
TODAY'S CHANGE (%)
Trending Up0.3800 (0.6579%)

Bid / Lots
56.5000/ 3
Ask / Lots
67.5000/ 21
Open / Previous Close
57.9600 / 57.7600
Day Range
Low 57.4100
High 58.5020
52 Week Range
Low 32.3100
High 61.4900
Volume
228,721
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 26, 2024
- DJ Vericel Is Maintained at Buy by BTIG, from 12:24PM ET on Tuesday Nov 26, 2024 by Dow Jones
  12:24PM ET on Tuesday Nov 26, 2024 by Dow Jones
  Companies Mentioned: VCEL
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/VCEL/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 26, 2024 12:24 ET (17:24 GMT)
Nov 19, 2024
- DJ Vericel Is Maintained at Buy by Canaccord Genuity, from 5:48PM ET on Tuesday Nov 19, 2024 by Dow Jones
  5:48PM ET on Tuesday Nov 19, 2024 by Dow Jones
  Companies Mentioned: VCEL
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/VCEL/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 19, 2024 17:48 ET (22:48 GMT)
Nov 11, 2024
- Truist Securities Raises Price Target on Vericel to $61 From $57, Maintains Buy Rating, from 7:46AM ET on Monday Nov 11, 2024 by MT Newswires
  7:46AM ET on Monday Nov 11, 2024 by MT Newswires
  Companies Mentioned: VCEL
  07:46 AM EST, 11/11/2024 (MT Newswires) -- Vericel (VCEL) has an average rating of buy and price targets ranging from $54 to $61, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research from major ban...
Nov 8, 2024
- DJ Vericel Price Target Maintained With a $60.00/Share by HC Wainwright & Co., from 6:20AM ET on Friday Nov 08, 2024 by Dow Jones
  6:20AM ET on Friday Nov 08, 2024 by Dow Jones
  Companies Mentioned: VCEL
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/VCEL/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 08, 2024 06:20 ET (11:20 GMT)
Nov 7, 2024
- Vericel's Q3 Net Loss Narrows, Revenue Increases, from 9:48AM ET on Thursday Nov 07, 2024 by MT Newswires
  9:48AM ET on Thursday Nov 07, 2024 by MT Newswires
  Companies Mentioned: VCEL
  09:48 AM EST, 11/07/2024 (MT Newswires) -- Vericel (VCEL) reported a Q3 net loss Thursday of $0.02 per diluted share, narrowing from a $0.08 net loss per share a year earlier. Analysts polled by Capital IQ expected a net loss of $0.05 per share. Rev...

Nov 29, 2024
- Astrazeneca's Enhertu, Orpathys Among 91 Drugs Added to China's National Reimbursement Drug List, from 8:09AM ET on Friday Nov 29, 2024 by MT Newswires
  8:09AM ET on Friday Nov 29, 2024 by MT Newswires
  Companies Mentioned: JNJ, MRK, SNY, ZLAB, AZN, BMY, BGNE
Nov 27, 2024
- Zai Lab Announces the Inclusion of AUGTYRO(R) (repotrectinib) for ROS1+ NSCLC and Other Updates in China's National Reimbursement Drug List, from 11:05PM ET on Wednesday Nov 27, 2024 by Dow Jones
  11:05PM ET on Wednesday Nov 27, 2024 by Dow Jones
  Companies Mentioned: ZLAB
Nov 26, 2024
- DJ Twist Bioscience Price Target Maintained With a $58.00/Share by TD Cowen, from 12:40PM ET on Tuesday Nov 26, 2024 by Dow Jones
  12:40PM ET on Tuesday Nov 26, 2024 by Dow Jones
  Companies Mentioned: TWST
- Kymera Therapeutics to Participate in Upcoming December Investor Conferences, from 7:00AM ET on Tuesday Nov 26, 2024 by Dow Jones
  7:00AM ET on Tuesday Nov 26, 2024 by Dow Jones
  Companies Mentioned: KYMR
Nov 25, 2024
- Asian Equities Traded in the US as American Depositary Receipts Edge Higher in Monday Trading, from 10:33AM ET on Monday Nov 25, 2024 by MT Newswires
  10:33AM ET on Monday Nov 25, 2024 by MT Newswires
  Companies Mentioned: HDB, PHI, WIT, ZLAB, IQ, UXIN, NIO, BEKE, TUYA
Nov 21, 2024
- Sector Update: Health Care Stocks Rise Pre-Bell Thursday, from 9:13AM ET on Thursday Nov 21, 2024 by MT Newswires
  9:13AM ET on Thursday Nov 21, 2024 by MT Newswires
  Companies Mentioned: IBB, JAZZ, PFE, XLV, ZYME, ZLAB, NRIX
- Zai Lab, Pfizer Collaborate for Marketing Antibacterial Drug in China, from 4:52AM ET on Thursday Nov 21, 2024 by MT Newswires
  4:52AM ET on Thursday Nov 21, 2024 by MT Newswires
  Companies Mentioned: ZLAB
- Zai Lab and Pfizer Announce Strategic Collaboration on the Novel Antibacterial Drug XACDURO(R) (Sulbactam-Durlobactam), from 4:00AM ET on Thursday Nov 21, 2024 by Dow Jones
  4:00AM ET on Thursday Nov 21, 2024 by Dow Jones
  Companies Mentioned: ZLAB
Nov 20, 2024
- AI's Growing Role in Transforming Healthcare Delivers Innovations in Diagnostics, Patient Care, from 9:15AM ET on Wednesday Nov 20, 2024 by CNW Group
  9:15AM ET on Wednesday Nov 20, 2024 by CNW Group
  Companies Mentioned: RDNT, SYK, TWST, AVAI, ABSI
- AI's Growing Role in Transforming Healthcare Delivers Innovations in Diagnostics, Patient Care, from 9:15AM ET on Wednesday Nov 20, 2024 by PR Newswire
  9:15AM ET on Wednesday Nov 20, 2024 by PR Newswire
  Companies Mentioned: RDNT, SYK, TWST, AVAI, ABSI

Vericel Corp
NASDAQ:VCELUnited States

Search Criteria

Nov 26, 2024

DJ Vericel Is Maintained at Buy by BTIG, from 12:24PM ET on Tuesday Nov 26, 2024 by Dow Jones

Nov 19, 2024

DJ Vericel Is Maintained at Buy by Canaccord Genuity, from 5:48PM ET on Tuesday Nov 19, 2024 by Dow Jones

Nov 11, 2024

Truist Securities Raises Price Target on Vericel to $61 From $57, Maintains Buy Rating, from 7:46AM ET on Monday Nov 11, 2024 by MT Newswires

Nov 8, 2024

DJ Vericel Price Target Maintained With a $60.00/Share by HC Wainwright & Co., from 6:20AM ET on Friday Nov 08, 2024 by Dow Jones

Nov 7, 2024

Vericel's Q3 Net Loss Narrows, Revenue Increases, from 9:48AM ET on Thursday Nov 07, 2024 by MT Newswires

Peers Headlines

Nov 29, 2024

Astrazeneca's Enhertu, Orpathys Among 91 Drugs Added to China's National Reimbursement Drug List, from 8:09AM ET on Friday Nov 29, 2024 by MT Newswires

Nov 27, 2024

Zai Lab Announces the Inclusion of AUGTYRO(R) (repotrectinib) for ROS1+ NSCLC and Other Updates in China's National Reimbursement Drug List, from 11:05PM ET on Wednesday Nov 27, 2024 by Dow Jones

Nov 26, 2024

DJ Twist Bioscience Price Target Maintained With a $58.00/Share by TD Cowen, from 12:40PM ET on Tuesday Nov 26, 2024 by Dow Jones

Kymera Therapeutics to Participate in Upcoming December Investor Conferences, from 7:00AM ET on Tuesday Nov 26, 2024 by Dow Jones

Nov 25, 2024

Asian Equities Traded in the US as American Depositary Receipts Edge Higher in Monday Trading, from 10:33AM ET on Monday Nov 25, 2024 by MT Newswires

Nov 21, 2024

Sector Update: Health Care Stocks Rise Pre-Bell Thursday, from 9:13AM ET on Thursday Nov 21, 2024 by MT Newswires

Zai Lab, Pfizer Collaborate for Marketing Antibacterial Drug in China, from 4:52AM ET on Thursday Nov 21, 2024 by MT Newswires

Zai Lab and Pfizer Announce Strategic Collaboration on the Novel Antibacterial Drug XACDURO(R) (Sulbactam-Durlobactam), from 4:00AM ET on Thursday Nov 21, 2024 by Dow Jones

Nov 20, 2024

AI's Growing Role in Transforming Healthcare Delivers Innovations in Diagnostics, Patient Care, from 9:15AM ET on Wednesday Nov 20, 2024 by CNW Group

AI's Growing Role in Transforming Healthcare Delivers Innovations in Diagnostics, Patient Care, from 9:15AM ET on Wednesday Nov 20, 2024 by PR Newswire